Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study

Keyphrases

• Bone Marrow 100%
• Bone Marrow Aspirate 100%
• Bone Marrow Biopsy 5%
• Bone Marrow Involvement 5%
• Bone Marrow Pathology 15%
• Clinical Role 5%
• Cox Regression Model 5%
• Diffuse Large B-cell Lymphoma (DLBCL) 100%
• Disease Stage 5%
• Flow Cytometry 100%
• Histologic 15%
• International Prognostic Index 10%
• Median Overall Survival 5%
• Median Progression-free Survival 5%
• Multivariable Cox Regression 5%
• Newly Diagnosed 5%
• No Significant Difference 5%
• Outcome Prediction 100%
• Overall Survival 10%
• Prognostic Score 5%
• Progression-free Survival 10%
• Single Institution 5%
• Single-center Study 100%
• Working Diagnosis 5%

Medicine and Dentistry

• Bone Marrow Biopsy 5%
• Diffuse Large B-Cell Lymphoma 100%
• Diseases 5%
• Flow Cytometry 100%
• International Prognostic Index 11%
• Overall Survival 16%
• Progression Free Survival 16%
• Proportional Hazards Model 5%